Loading clinical trials...

Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint) | Clinical Trials | Clareo Health

UNKNOWNNA

Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)

Phase 1/2 Study of Autologous Tissues/Body Surface Organs Prefabrication in Tissue Reconstruction

NCT02595047•Shanghai Jiao Tong University School of Medicine

Summary

The purpose of this study is to observe the feasibility and its application of autologous prefabrication for body surface tissues/oranges

Detailed Description

In the field of tissue regeneration techniques, the in vitro processes and other exogenous factors still have many uncertainties. These uncertainties have hampered road to the clinical application. As the importance of in vivo environment has aroused more awareness, the investigators validated the hypothesis that the feasibility of self-regeneration prefabricated unaided by any in vitro culture process or exogenous elements.

Eligibility

Age

5 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•With body surface tissue or organ defects (e.g., ear, nose, bone and joint) requiring reconstruction.

Exclusion Criteria

•evidence of infection, ischemia, ulcer or other pathological changes within the prefabricated area which defined as not suitable for tissues regeneration
•history of delayed healing, radiational therapy;
•significant renal, cardiovascular, hepatic and psychiatric diseases;
•significant medical diseases or infection (including but not limited to the carrier of hepatitis B virus or HIV);
•BMI \>30;
•history of any hematological disease, including leukopenia, thrombocytopenia, or thrombocytosis;
•Evidence of malignant diseases
•unwillingness to participate.

Locations (1)

Shanghai Ninth People's Hospital, Affliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

January 1, 2013

Primary Completion Date

June 1, 2015

Completion Date

December 1, 2016

Last Updated

November 3, 2015

Enrollment

ESTIMATED participants

Conditions

Soft Tissue InfectionsIntentional Self Harm by Other Specified Means

Interventions

tissue/ organ prefabrication

PROCEDURE

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites

NCT05814003

Soft Tissue InfectionsGingival Recession

View study

COMPLETEDPHASE2

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

NCT03643952

BacteremiaSoft Tissue Infections+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 3, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)

Inclusion Criteria

Exclusion Criteria

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

VACuum-Assisted Closure for Necrotizing Soft Tissue infecTIONs

The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Hyperbaric Oxygen Therapy Registry